Establishing a new role for real world evidence
Interviewee/Contributor
Tara Raveendran
Organisation
Shore Capital Ltd
Strategy
The role of base and prime editing in therapeutics
Interviewee/Contributor
Jonathan Frampton
Organisation
Horizon Discovery Group Plc
The race to develop a COVID-19 vaccine
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Coronavirus pandemic ushers in new collaborations
Interviewee/Contributor
Victoria English
Organisation
MedNous
ReiThera rallies partners around candidate vaccine
Interviewee/Contributor
Antonella Folgori
Organisation
ReiThera Srl
Unlocking the potential of PSMA as a cancer target
Interviewee/Contributor
Brian McGuinness and Theodora Harold
Organisation
Crescendo Biologics Ltd
Industry and public sector collaborate on recovery
Interviewee/Contributor
Victoria English
Organisation
MedNous
Exploiting the measles vector platform for vaccines
Interviewee/Contributor
Erich Tauber
Organisation
Themis Bioscience GmbH
COVID-19's logistical impact on advanced therapies
Interviewee/Contributor
Matthew Lakelin
Organisation
TrakCel Ltd
Solving the viral vector bottleneck during a pandemic
Interviewee/Contributor
Géraldine Guérin-Peyrou
Organisation
Polyplus-transfection SA